LCN2 and Cognitive impairment: In addition, other studies have shown that LCN2 protein levels in the blood increase both with age and with mild cognitive impairment, and are also increased in human post-mortem brain specimens with different diseases of the central nervous system, including AD, Parkinson’s disease, and multiple sclerosis [41,42,43,44].